Ramdial J, Lin R, Thall PF, Valdez BC, et al. High activity of the new myeloablative regimen of gemcitabine/clofarabine/busulfan for allogeneic transplant for aggressive lymphomas. Bone Marrow Transplant 2024;59:1754-1762.
PMID: 39341929